Want to join the conversation?
New York-based biopharmaceutical firm $BMY posted 4Q15 net loss attributable to the company of $138MM or $0.08 per share, hurt by higher expenses. This compared to net earnings of $13MM or $0.01 per share in 4Q14. Revenue of $4.3Bil grew 1% compared to last year. Non-GAAP net earnings attributable to $BMY were $647MM or $0.38 per share in 4Q15.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.